Human Gene MIR34B (ENST00000385076.3) from GENCODE V44
|
|
Sequence and Links to Tools and Databases
|
|
Primer design for this transcript
|
|
Comparative Toxicogenomics Database (CTD)
|
|
The following chemicals interact with this gene
| |
|
|
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
JD024317 - Sequence 5341 from Patent EP1572962. CS266367 - Sequence 59 from Patent WO2005118806. DL076529 - METHODS AND COMPOSITIONS INVOLVING MicroRNA. DM004179 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. FU261116 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763618 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FW421521 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. FW504785 - COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER. HI508136 - Sequence 5 from Patent EP2152722. HV304517 - JP 2009531018-A/84: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305015 - JP 2009531019-A/84: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HV444479 - JP 2011515078-A/11: TREATMENT, DIAGNOSTIC, AND METHOD FOR DISCOVERING ANTAGONIST USING SPARC SPECIFIC MIRNAS. HV753790 - JP 2012509675-A/28: COMPOSITIONS AND METHODS FOR DETECTING SMALL RNAS, AND USES THEREOF. HW102016 - JP 2013500034-A/143: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells. HW119224 - JP 2013046612-A/84: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW367392 - JP 2012228254-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW411785 - JP 2014000079-A/59: METHODS AND COMPOSITIONS INVOLVING MicroRNA. HW505122 - JP 2014502606-A/24: MELANOMA TREATMENTS. HW589553 - JP 2013121348-A/84: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HW674131 - JP 2014217381-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ043220 - JP 2015510401-A/310: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ067073 - JP 2014012020-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ081846 - JP 2015514392-A/310: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ408234 - JP 2015528002-A/831: CHIRAL CONTROL. HZ413357 - JP 2014060993-A/84: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ427497 - JP 2014217384-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ428300 - JP 2014217385-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429103 - JP 2014217386-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429906 - JP 2014217387-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ501568 - JP 2016025853-A/84: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ769163 - JP 2014223080-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. JA058557 - Sequence 59 from Patent EP2298893. JA059360 - Sequence 59 from Patent EP2298894. JA073683 - Sequence 59 from Patent EP2281887. JA104820 - Sequence 59 from Patent EP2302051. JA106160 - Sequence 59 from Patent EP2302052. JA106963 - Sequence 59 from Patent EP2302053. JA107766 - Sequence 59 from Patent EP2302054. JA108569 - Sequence 59 from Patent EP2302055. JA109372 - Sequence 59 from Patent EP2302056. JA191888 - Sequence 59 from Patent EP2290066. JA192787 - Sequence 59 from Patent EP2290067. JA193686 - Sequence 59 from Patent EP2290068. JA194585 - Sequence 59 from Patent EP2290069. JA195484 - Sequence 59 from Patent EP2290070. JA196383 - Sequence 59 from Patent EP2290071. JA197282 - Sequence 59 from Patent EP2290072. JA198181 - Sequence 59 from Patent EP2290073. JA199080 - Sequence 59 from Patent EP2290074. JA199979 - Sequence 59 from Patent EP2290075. JA200878 - Sequence 59 from Patent EP2290076. JA218000 - Sequence 59 from Patent EP2281888. JA226151 - Sequence 59 from Patent EP2292755. JA229006 - Sequence 59 from Patent EP2292756. JA257277 - Sequence 59 from Patent EP2284265. JA278557 - Sequence 59 from Patent EP2281886. JA284443 - Sequence 59 from Patent EP2281889. JA292496 - Sequence 59 from Patent EP2287303. JA317682 - Sequence 59 from Patent EP2314688. JA374741 - Sequence 59 from Patent EP2322616. JA525934 - Sequence 84 from Patent EP2369011. JA526441 - Sequence 84 from Patent EP2369012. JA526948 - Sequence 84 from Patent EP2369013. JA535877 - Sequence 84 from Patent EP2371971. JA787882 - Sequence 84 from Patent EP2479285. JA788380 - Sequence 84 from Patent EP2479286. JA810714 - Sequence 84 from Patent EP2468890. JA811212 - Sequence 84 from Patent EP2468891. JA811710 - Sequence 84 from Patent EP2468893. JA812208 - Sequence 84 from Patent EP2468894. JA812706 - Sequence 84 from Patent EP2468895. JA813204 - Sequence 84 from Patent EP2468896. JA813702 - Sequence 84 from Patent EP2468897. JA814200 - Sequence 84 from Patent EP2468898. JA814698 - Sequence 84 from Patent EP2468899. JA816941 - Sequence 84 from Patent EP2468892. JA825753 - Sequence 84 from Patent EP2471956. JA826251 - Sequence 84 from Patent EP2471958. JB024538 - Sequence 84 from Patent EP2505668. JB025036 - Sequence 84 from Patent EP2505669. JB037923 - Sequence 39 from Patent WO2012107841. JB079423 - Sequence 84 from Patent EP2487252. JB079921 - Sequence 84 from Patent EP2487253. JB080419 - Sequence 84 from Patent EP2487254. JB080917 - Sequence 84 from Patent EP2487255. JB081415 - Sequence 84 from Patent EP2487256. JB081913 - Sequence 84 from Patent EP2487257. JB082411 - Sequence 84 from Patent EP2487258. JB082909 - Sequence 84 from Patent EP2487259. JB083407 - Sequence 84 from Patent EP2487260. JB083905 - Sequence 84 from Patent EP2487261. JB084403 - Sequence 84 from Patent EP2487262. JB084901 - Sequence 84 from Patent EP2487263. JB087579 - Sequence 84 from Patent EP2502630. JB147783 - Sequence 84 from Patent EP2484782. JB148281 - Sequence 84 from Patent EP2484783. JB153006 - Sequence 84 from Patent EP2514433. JB153504 - Sequence 84 from Patent EP2514434. JB622093 - Sequence 84 from Patent EP2586454. JB622591 - Sequence 84 from Patent EP2586455. JC001654 - Sequence 84 from Patent EP2591794. JC221584 - Sequence 59 from Patent EP2471923. JC268150 - Sequence 59 from Patent EP2471924. JC340458 - Sequence 59 from Patent EP2471922. JC469704 - Sequence 59 from Patent EP2471921. JC572001 - Sequence 15 from Patent EP2759595. JC990493 - Sequence 59 from Patent EP2808390. JD020155 - Sequence 1179 from Patent EP1572962. LF132450 - JP 2016506923-A/15: Composition comprising an encapsulated antagomir. LF404317 - JP 2015509366-A/310: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF714596 - JP 2016165292-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. LF856530 - JP 2015142597-A/59: METHODS AND COMPOSITIONS INVOLVING MicroRNA. LG051568 - KR 1020150036642-A/834: CHIRAL CONTROL. LG162314 - KR 1020160018451-A/15: Composition comprising an encapsulated antagomir. LQ101334 - Sequence 39 from Patent WO2015101653. LQ276049 - Sequence 39 from Patent WO2016071729. MA259142 - JP 2017502699-A/39: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS. MA353848 - JP 2018075017-A/310: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MP045488 - Sequence 310 from Patent EP3401394. MP084158 - Sequence 310 from Patent EP3401393. FZ421158 - JP 2010539978-A/58: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF. HW502472 - JP 2014050389-A/58: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF. CS548418 - Sequence 1448 from Patent EP1777301. FU757830 - Method for detection of cancer. FV524041 - Diagnosis and therapeutic choice of gynecologic cancer using micro RNA as biomarker. FW312160 - DETECTING NUCLEIC ACIDS. FW364247 - Oligonucleotides for modulating target RNA activity. FW393830 - Diagnosis and therapeutic choice of gynecologic cancer using micro RNA as biomarker. HI965150 - Sequence 435 from Patent WO2010139812. HI966325 - Sequence 645 from Patent WO2010139811. HI967191 - Sequence 645 from Patent WO2010139810. HV036072 - WO 2011027893-A/3: A method for predicting the efficacy of chronic hepatitis C treatment. HV534433 - WO 2011111715-A/949: Nucleic acid for controlling cell cycle. HV595156 - JP 2010539959-A/537: Micromirs. HV753792 - JP 2012509675-A/30: COMPOSITIONS AND METHODS FOR DETECTING SMALL RNAS, AND USES THEREOF. HW101964 - JP 2013500034-A/91: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells. HW505491 - JP 2014502606-A/393: MELANOMA TREATMENTS. HW612384 - JP 2014140377-A/2: Method for detection of cancer. HW906897 - WO 2015037656-A/112: Autophagy-regulating microRNA. HZ043111 - JP 2015510401-A/201: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ074162 - JP 2013535982-A/253: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ081737 - JP 2015514392-A/201: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ157713 - JP 2015130862-A/537: Micromirs. HZ186560 - JP 2015146814-A/309: Oligonucleotides for modulating target RNA activity. HZ466306 - JP 2015531594-A/9: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS. HZ480237 - JP 2015535430-A/743: TERMINALLY MODIFIED RNA. HZ790168 - JP 2016504050-A/1913: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA287409 - Sequence 91 from Patent WO2011015720. JA401188 - Sequence 435 from Patent WO2011080318. JA402166 - Sequence 435 from Patent WO2011080315. JA403173 - Sequence 435 from Patent WO2011080316. JA405804 - Sequence 435 from Patent EP2336353. JA427082 - Sequence 415 from Patent WO2011072177. JA429330 - Sequence 435 from Patent WO2011095623. JA660659 - Sequence 113 from Patent WO2011131354. JA757965 - Sequence 98 from Patent WO2012010584. JB022815 - Sequence 69 from Patent WO2013026684. JB037924 - Sequence 40 from Patent WO2012107841. JB136693 - Sequence 3 from Patent EP2476758. JB620063 - Sequence 43 from Patent WO2013063544. JB620338 - Sequence 318 from Patent WO2013063544. JC265632 - Sequence 2 from Patent WO2013017542. JC334247 - Sequence 165 from Patent EP2487240. JC512900 - Sequence 3153 from Patent WO2014113089. JC572034 - Sequence 48 from Patent EP2759595. JE869361 - Sequence 2 from Patent WO2015131115. JE978668 - Sequence 113 from Patent EP2865765. LF132483 - JP 2016506923-A/48: Composition comprising an encapsulated antagomir. LF159955 - JP 2016513950-A/21: Oligomers with improved off-target profile. LF404208 - JP 2015509366-A/201: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF636393 - JP 2016519076-A/167: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS. LF838609 - JP 2016530232-A/4: Biomarkers of miR-34 Activity. LG134550 - KR 1020150131312-A/168: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS. LG162347 - KR 1020160018451-A/48: Composition comprising an encapsulated antagomir. LP636952 - Sequence 2 from Patent EP2848702. LP726951 - Sequence 645 from Patent EP2883966. LP819221 - Sequence 645 from Patent EP3296406. LP939163 - Sequence 645 from Patent EP3184651. LP997075 - Sequence 24 from Patent WO2017136662. LQ069374 - Sequence 2 from Patent WO2015153757. LQ070488 - Sequence 812 from Patent EP2964234. LQ101335 - Sequence 40 from Patent WO2015101653. LQ276050 - Sequence 40 from Patent WO2016071729. LQ417676 - Sequence 12 from Patent WO2016125163. LY405221 - KR 1020160117535-A/526: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LY409557 - KR 1020160122850-A/2: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER. LZ233917 - JP 2017184756-A/309: Oligonucleotides for modulating target RNA activity. LZ986416 - JP 2017225396-A/18: Complex and use thereof. LZ991537 - WO 2017221875-A/18: COMPLEX AND USE THEREOF. MA259143 - JP 2017502699-A/40: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS. MA260460 - JP 2017505623-A/526: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA264539 - JP 2017507955-A/2: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER. MA353739 - JP 2018075017-A/201: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MA625403 - JP 2018138044-A/9: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS. MA643989 - JP 2017113010-A/1913: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA731873 - JP 2017140048-A/743: TERMINALLY MODIFIED RNA. MP029287 - Sequence 9 from Patent WO2018219998. MP045379 - Sequence 201 from Patent EP3401394. MP073577 - Sequence 24 from Patent WO2018236590. MP075718 - Sequence 57 from Patent WO2019002265. MP080350 - Sequence 24 from Patent WO2018236589. MP084049 - Sequence 201 from Patent EP3401393. MS673266 - Sequence 69 from Patent EP3135774. MS834289 - Sequence 435 from Patent EP3112479. DQ601590 - Homo sapiens piRNA piR-39656, complete sequence. DQ592638 - Homo sapiens piRNA piR-59750, complete sequence. DJ003843 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof. DJ027122 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof. FU261389 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763891 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FW504784 - COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER. HH981319 - Sequence 79 from Patent EP1723162. HI508135 - Sequence 4 from Patent EP2152722. HV304790 - JP 2009531018-A/357: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305288 - JP 2009531019-A/357: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HV954027 - JP 2012518421-A/939: METHODS OF DETECTING LUNG CANCER. HW119497 - JP 2013046612-A/357: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW589826 - JP 2013121348-A/357: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HZ413630 - JP 2014060993-A/357: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ501841 - JP 2016025853-A/357: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. JA526207 - Sequence 357 from Patent EP2369011. JA526714 - Sequence 357 from Patent EP2369012. JA527221 - Sequence 357 from Patent EP2369013. JA536150 - Sequence 357 from Patent EP2371971. JA715157 - Sequence 939 from Patent EP2401406. JA788155 - Sequence 357 from Patent EP2479285. JA788653 - Sequence 357 from Patent EP2479286. JA810987 - Sequence 357 from Patent EP2468890. JA811485 - Sequence 357 from Patent EP2468891. JA811983 - Sequence 357 from Patent EP2468893. JA812481 - Sequence 357 from Patent EP2468894. JA812979 - Sequence 357 from Patent EP2468895. JA813477 - Sequence 357 from Patent EP2468896. JA813975 - Sequence 357 from Patent EP2468897. JA814473 - Sequence 357 from Patent EP2468898. JA814971 - Sequence 357 from Patent EP2468899. JA817214 - Sequence 357 from Patent EP2468892. JA826026 - Sequence 357 from Patent EP2471956. JA826524 - Sequence 357 from Patent EP2471958. JB024811 - Sequence 357 from Patent EP2505668. JB025309 - Sequence 357 from Patent EP2505669. JB079696 - Sequence 357 from Patent EP2487252. JB080194 - Sequence 357 from Patent EP2487253. JB080692 - Sequence 357 from Patent EP2487254. JB081190 - Sequence 357 from Patent EP2487255. JB081688 - Sequence 357 from Patent EP2487256. JB082186 - Sequence 357 from Patent EP2487257. JB082684 - Sequence 357 from Patent EP2487258. JB083182 - Sequence 357 from Patent EP2487259. JB083680 - Sequence 357 from Patent EP2487260. JB084178 - Sequence 357 from Patent EP2487261. JB084676 - Sequence 357 from Patent EP2487262. JB085174 - Sequence 357 from Patent EP2487263. JB087852 - Sequence 357 from Patent EP2502630. JB148056 - Sequence 357 from Patent EP2484782. JB148554 - Sequence 357 from Patent EP2484783. JB153279 - Sequence 357 from Patent EP2514433. JB153777 - Sequence 357 from Patent EP2514434. JB256160 - Sequence 79 from Patent EP2327710. JB622366 - Sequence 357 from Patent EP2586454. JB622864 - Sequence 357 from Patent EP2586455. JC001927 - Sequence 357 from Patent EP2591794. JD030366 - Sequence 11390 from Patent EP1572962. FW364246 - Oligonucleotides for modulating target RNA activity. FW504816 - COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER. FZ414228 - WO 2011007815-A/118: A method for screening a food which promotes production of milk having immunoregulating effect. HI508167 - Sequence 36 from Patent EP2152722. HI965151 - Sequence 436 from Patent WO2010139812. HI965816 - Sequence 136 from Patent WO2010139811. HI966682 - Sequence 136 from Patent WO2010139810. HV444519 - JP 2011515078-A/51: TREATMENT, DIAGNOSTIC, AND METHOD FOR DISCOVERING ANTAGONIST USING SPARC SPECIFIC MIRNAS. HV543936 - JP 2011217617-A/47: Method for testing fibrosis of chronic liver diseases using miRNAs. HV595155 - JP 2010539959-A/536: Micromirs. HV753791 - JP 2012509675-A/29: COMPOSITIONS AND METHODS FOR DETECTING SMALL RNAS, AND USES THEREOF. HV821756 - JP 2011140513-A/118: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition. HW101912 - JP 2013500034-A/39: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells. HW505311 - JP 2014502606-A/213: MELANOMA TREATMENTS. HZ074163 - JP 2013535982-A/254: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ083047 - JP 2015513906-A/404: Stem Cell Microparticles. HZ157712 - JP 2015130862-A/536: Micromirs. HZ186559 - JP 2015146814-A/308: Oligonucleotides for modulating target RNA activity. HZ436828 - JP 2015529450-A/404: Stem Cell Microparticles. HZ480236 - JP 2015535430-A/742: TERMINALLY MODIFIED RNA. HZ790167 - JP 2016504050-A/1912: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA287357 - Sequence 39 from Patent WO2011015720. JA401189 - Sequence 436 from Patent WO2011080318. JA402167 - Sequence 436 from Patent WO2011080315. JA403174 - Sequence 436 from Patent WO2011080316. JA405805 - Sequence 436 from Patent EP2336353. JA426673 - Sequence 6 from Patent WO2011072177. JA429331 - Sequence 436 from Patent WO2011095623. JA462540 - Sequence 17 from Patent WO2011070297. JA667971 - Sequence 50 from Patent WO2011139911. JA682635 - Sequence 103 from Patent WO2011149354. JB037925 - Sequence 41 from Patent WO2012107841. JB149043 - Sequence 118 from Patent EP2455486. JB387961 - Sequence 2 from Patent WO2012041959. JB620339 - Sequence 319 from Patent WO2013063544. JC172032 - Sequence 404 from Patent WO2013150303. JC244960 - Sequence 588 from Patent WO2012020308. JC512899 - Sequence 3152 from Patent WO2014113089. JC572033 - Sequence 47 from Patent EP2759595. JC572843 - Sequence 404 from Patent WO2014125276. JC582531 - Sequence 404 from Patent WO2014125277. JE954227 - Sequence 404 from Patent WO2015052526. JE955980 - Sequence 404 from Patent WO2015052527. LF132482 - JP 2016506923-A/47: Composition comprising an encapsulated antagomir. LF137732 - JP 2016507550-A/404: Method of Producing Microparticles. LF160404 - JP 2016513950-A/470: Oligomers with improved off-target profile. LF162697 - JP 2016513095-A/404: Stem Cell Microparticles and miRNA. LF953449 - JP 2016534103-A/404: Stem Cell Microparticles and miRNA. LG005794 - KR 1020150004822-A/404: STEM CELL MICROPARTICLES. LG046506 - KR 1020150023687-A/51: Oligonucleotide-Based Inhibitors Comprising Locked Nucleic Acid Motif. LG053490 - KR 1020150059168-A/404: STEM CELL MICROPARTICLES. LG162346 - KR 1020160018451-A/47: Composition comprising an encapsulated antagomir. LG240729 - KR 1020160035087-A/404: STEM CELL MICROPARTICLES AND MIRNA. LP726442 - Sequence 136 from Patent EP2883966. LP769477 - Sequence 4 from Patent EP3294910. LP818712 - Sequence 136 from Patent EP3296406. LP938654 - Sequence 136 from Patent EP3184651. LQ070487 - Sequence 811 from Patent EP2964234. LQ101336 - Sequence 41 from Patent WO2015101653. LQ276051 - Sequence 41 from Patent WO2016071729. LQ278634 - Sequence 173 from Patent WO2016066288. LQ417677 - Sequence 13 from Patent WO2016125163. LQ724396 - Sequence 29 from Patent WO2018096084. LQ840941 - Sequence 51 from Patent EP3354734. LV470814 - JP 2016534036-A/404: Stem Cell Microparticles and miRNA. LV746126 - JP 2015521626-A/51: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF. LY405220 - KR 1020160117535-A/525: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LZ233916 - JP 2017184756-A/308: Oligonucleotides for modulating target RNA activity. MA259144 - JP 2017502699-A/41: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS. MA260459 - JP 2017505623-A/525: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA400817 - JP 2018515097-A/4: Method for Diagnosis and Prognosis of Chronic Heart Failure. MA643988 - JP 2017113010-A/1912: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA731872 - JP 2017140048-A/742: TERMINALLY MODIFIED RNA. MP015104 - Sequence 307 from Patent WO2019016252. MS834290 - Sequence 436 from Patent EP3112479. AY940857 - Homo sapiens microRNA hsa-mir-RG-114 variant 2, complete sequence. AY940856 - Homo sapiens microRNA hsa-mir-RG-114 variant 1, complete sequence. MA801042 - JP 2018183181-A/1913: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA801041 - JP 2018183181-A/1912: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MP174435 - Sequence 20 from Patent WO2019058253. MP129504 - Sequence 404 from Patent EP3470073. MP162427 - Sequence 404 from Patent WO2019069093. MA896108 - JP 2017217007-A/51: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF. MP280757 - Sequence 177 from Patent WO2019111197. MP283670 - Sequence 177 from Patent WO2019111198. MB408329 - WO 2019163900-A/36: Method of analysis and diagnose using RNA modification.
| |
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: ENST00000385076.1, ENST00000385076.2, NR_029839, uc001plm.1, uc001plm.2, uc001plm.3, uc001plm.4 UCSC ID: ENST00000385076.3 RefSeq Accession: NR_029839
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|